Cultural High

Dustin Robinson, founder of Mr. Cannabis Law, discusses the impact of AI on the legal industry and how his firm is utilizing this technology in the cannabis and psychedelic space. He explains that AI can streamline activities such as application drafting, client intake, and billing, ultimately reducing time spent and providing more cost-effective services to clients. Dustin also highlights the common issues faced by new licensees in the cannabis industry and emphasizes the importance of working with an attorney to navigate the complex legal landscape. Dustin Robinson is the founder of Mr. Cannabis Law, a law firm specializing in the cannabis industry, and Eater Investments, an investment fund. With a background in running a manufacturing company and a passion for embracing technology, Dustin is at the forefront of using AI to streamline legal processes in the cannabis and psychedelic space.

Nathan Johnson, CEO of Vern Bioanalytics, discusses the challenges of treating cancer and the potential of cannabis in cancer research. He explains that cancer is a result of cells not receiving the right signals to stop dividing and that there are various mechanisms involved in tumor growth. 

Nathan emphasizes the importance of understanding cannabis and its complex components in order to effectively use it as a tool in cancer treatment. He also mentions that while some studies have shown the positive effects of cannabis on cancer cells, there are cases where it can actually make the tumor grow faster. Nathan shares his personal observations and highlights the need for further research to understand why cannabis works for some individuals but not for others.

Nathan Johnson, Ph.D., is the co-founder and CEO of Vern Bioanalytics in Massachusetts. With a background in the pharmaceutical sector, Nathan has extensive experience in analyzing vast amounts of data to find patterns and make a difference in the field of cancer research. He is passionate about using AI and cannabis to tackle complex diseases and improve patient outcomes.

Tia Moskalenko, a writer for Ask Growers, shares her experiences with cannabis and discusses the current state of cannabis legalization in Ukraine. She emphasizes the importance of educating people about cannabis and its potential benefits. 

Tia also highlights the need for relaxation and mental health support, especially for those affected by the war in Ukraine. She expresses her hope for the future legalization of cannabis in the country.

Tia is a cannabis enthusiast and writer for Ask Growers, a website that provides comprehensive information about cannabis strains, products, brands, and dispensaries. She is passionate about educating people about the benefits of cannabis and breaking the stigma surrounding its use.

Back for Part 2! While testing out some products they continue discussing their experiences with corporations in the cannabis industry, including their involvement in different states and the challenges they face.

 Brandon explains the concept behind TCK Genetics and the value of holding onto genetics in a market dominated by corporations. 

They also discuss the cannabis scene in Phoenix and their plans for future events and strain development. Overall, the conversation highlights the need for more boutique and craft cannabis options in the market.

On today's episode, they discuss their experiences with corporations in the cannabis industry, including their involvement in different states and the challenges they face. They talk about their time working on a cannabis talk show and the importance of education in the industry.

 Brandon explains the concept behind TCK Genetics and the value of holding onto genetics in a market dominated by corporations. 

They also discuss the cannabis scene in Phoenix and their plans for future events and strain development. Overall, the conversation highlights the need for more boutique and craft cannabis options in the market.

Stephen Gray is an author, editor, event organizer and speaker, and ceremony leader. He has been deeply involved with spiritual practices and sacramental (psychedelic) medicine work for over 40 years, including Tibetan Buddhism, the Native American Church (peyote prayer ceremonies), and ayahuasca. 

Stephen is an influential figure in the Sacramento psychedelic and cannabis space, having been an editor, event organizer, speaker, ceremony leader, and thought leader over the last 40 years. He has faced ridicule and stigma for his views but believes his involvement has helped bring about a modern renaissance in psychedelic and cannabis use. When asked where he got his start in this movement, Stephen said he believes he was involved with the Tibetans over 1000 years ago, but more realistically, his age has been a major factor in his involvement. He has written three books, with his most recent one being How Psychedelics Can Help Save the World. Stephen has also been involved with spiritual awakenings and Tibetan Buddhism, as well as the Native American Church

From How Psychedelics Can Help Save the World: Exploring the way forward for Humanity in the Face of unprecedented crisis, more than 25 contributors show how the wisdom of Indigenous peoples and the power of psychedelics can help us enact the radical shift in consciousness necessary to navigate the collapse of the old world order and the birth of a new consciousness.

Visionary and Indigenous Voices Speak Out: We hear from psychedelic visionaries Christopher Bache, Zoe Helene, Wade Davis, Chris Kilham, Laurel Sugden, and others on the promise of psychedelic medicines for spiritual and healing work. We learn about Indigenous stories to support our transformation from Native American leader Solana Booth, ancestral memory from Grandmother Maria Alice Campos Freire, cannabis’s role in world building from Minelli Eustàcio-Costa, the ritual roots of talking plants from Michael Stuart Ani, and alchemy across the arc of time from shaman Ya’Acov Darling Khan. 

Clearmind Medicine has, and continues to build, a culture of world-leading innovators in novel psychedelics. Learn more about the team we’ve created so far.

Dr. Adi Zuloff-Shani is a Biomedical Research and Development Executive with a vast experience with over 20 years of strategic and operational leadership in the healthcare industry and a deep understanding of therapeutics development in heavily regulated environments.

Previously the Executive Director of MAPS (Multidisciplinary Association for Psychedelic Studies) Canada for 10 years, Mark is an adjunct professor at the University of British Columbia School of Population and Public Health and has published on the issue of drug control policy and psychedelics. Mark also worked in the addictions field in counseling, supervisory and management positions for 28 years. Mark has provided public education on drugs and drug policy for over 30 years. 

Today we speak with Gelato CEO and Co-Founder George Sadler to discuss the future of the brand. From his massive success with his son Cody launching and selling House of Platinum, to his new father and son venture at Gelato, George has been an industry giant in California since the first time he stepped foot in the scene.

Expanding its edible lineup with the waffle cone and infused chocolate treat, Last Bite, George chats with us to talk about how it’s going with Gelato and what the future may hold.

Michael Sassano was an early investor in the United States cannabis industry and now heads SOMAÍ Pharmaceuticals, a next-generation biotech company centered on the cultivation, manufacturing, and distribution of GMP-certified cannabinoid-containing pharmaceutical products throughout the European Union. SOMAÍ opened Europe’s largest cannabis manufacturing facility earlier this year in Lisbon, Portugal.

Michael Sassano is one of the most respected executives in the pharmaceutical cannabis space today. He was an early investor in the cannabis industry in the United States; today he is celebrated in mainstream business and biopharma media as an international authority on developing large-scale cannabis infrastructures throughout the world and the most advanced pharmaceutical cannabinoid products. Michael is also widely respected for successfully predicting long-term cannabis market trends and movements, which he generously shares in many forums.

The SLANG portfolio is strategically structured to produce uniquely positioned, scalable brands and products in some of the highest-volume cannabis consumable categories. Their portfolio consists of 3 distinct CPG brands, 1 retail brand, and a product portfolio of 30 SKUs that have a proven track record of success. 

SLANG's products are regularly on the leaderboard as top performers in the states in which they operate. From coast to coast, consumers can expect high-quality and consistent products from the SLANG family of brands.

Their company has over 11 years of experience operating in legal cannabis, across numerous state markets and in nearly every product vertical. Operating in a nascent and highly regulated industry isn’t for the faint of heart, when you partner with SLANG, you’ll get the benefits of their experience and our playbook for being a successful operator, from operations to sales and marketing, in one of the fastest-growing industries. 

They're committed to continuing to lead the industry in brand and product leadership with a focus on maintaining a strong product development pipeline that satisfies the evolving cannabis consumer’s needs.